W11 - Depression Flashcards

1
Q

What is Psychiatry?

A

Psychiatry
– Branch of medicine, diagnosis & treatment of
disorders that affect the mind or psyche
– Disorder of thoughts, moods and fears
considered outside reach of neuroscience
– Now hope that neuroscience will help identify
causes and treatment of mental illness
* Anxiety, depression, schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens with mental illness?

A
  • Human behaviour
    – Product of brain activity
  • Brain
    – Product of genetics and environment
    – Experience (trauma / disease)
    – Genetic make-up and experience can interact,
    making a person more or less susceptible to
    future experience
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some facts about mental illnesses?

A
  • In 2020, of the estimated 971 million people worldwide living with mental or behavioral
    disorders, including drug or alcohol dependent, schizophrenia, and depression
    (WHO,2020)
  • 1 in 4 British adults experience at least one diagnosable mental health problem in any
    one year (The Office for National Statistics Psychiatric Morbidity report)
  • One in ten children between the ages of one and 15 has a mental health disorder (The
    Office for National Statistics Mental Health in children and young people in Great Britai )
  • Depression affect 1 in 5 older people living in the community
  • More than 70% of the prison population has two or more mental health disorders (Social
    Exclusion Unit quoting Psychiatric Morbidity Among Prisoners In England And Wales)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is happening with antidepressants?

A

Millions of prescriptions for SSRIs are written up in the UK each year, but a major study says they’re no better than placebo.
What now for the citizens of Prozac Nation?

-Around 65 million prescriptions of antidepressants given in the UK every year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of depression?

A
  • Characteristics of Affective Disorders
    – Disorders of mood rather than thought / cognition
    – Most common is depression
    – Major cause of premature death and disability
  • 1) Unipolar Depression
    – Mood swings in one direction
    – Most common depressive illness
    – 75% cases REACTIVE (induced by environmental factors)
    – 25% cases ENDOGENOUS (genetic)
  • 2) Bipolar Depression
    – Oscillation between depression and mania
    – Mania: excessive exuberance, enthusiasm, self confidence, impulsive actions, aggression, irritability, delusions of grandiose
    – Type I: More mania episodes with or without depression (1%pop)
    – Type II:Hypomania and always episodes of major depression (0.6%)
    – Onset usually in adult life
    – Strong hereditary tendency (no genes found yet)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a major depressive episode? What are some characteristics?

A

DSM V - Major Depressive Episode
Five (or more) of the following symptoms have been present during the same 2-week
period and represent a change from previous functioning; at least one of the symptoms
is either (1) depressed mood or (2) loss of interest or pleasure.

*Note: Do note include symptoms that are clearly due to a general medical condition, or
mood-incongruent delusions or hallucinations.

1) Depressed mood most of the day, nearly every day (in children irritable mood)
2) Markedly diminished interest or pleasure in all, or almost all, activities most of the
day, nearly every day.
3) Significant weight loss when not dieting or weight gain, or decrease or increase in
appetite nearly every day.
4) A slowing down of thought and a reduction of physical movement (observable by
others, not merely subjective feelings of restlessness or being slowed down).
5) Fatigue or loss of energy nearly every day.
6) Feelings of worthlessness or excessive or inappropriate guilt nearly every day.
7) Diminished ability to think or concentrate, or indecisiveness, nearly every day.
8)Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the symptomology: ICD-10?

A
  • Emotional symptoms (Q)
    – Apathy, pessimism, negativity
    – Low self esteem, feeling guilty
    – Loss of motivation
    – Indecisiveness
  • Biological symptoms (Q)
    – Reduced activity
    – Loss of libido
    – Sleep disturbance
    – Loss of appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Co-morbidity?

A

General medical conditions in which you often find depression
* Terminal illness
* Chronic illness (e.g. chronic pain)
* Thyroid dysfunction
* Neurological disease
* Stroke
* Drug abuse
* Parkinson’s disease
* anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a major theory of depression?

A

Monoamine Theory (Schildkraut, 1965)
* Evidence For
– Overall reduced activity of central noradrenergic and / or serotonergic systems
– Reserpine depletes brain of NA and 5-HT
induces depression
– Main antidepressant drugs increased [amines] in brain (Q devise drugs to treat depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is evidence against the monoamine theory?

A
  • Evidence Against
    – Difficult to show deficits in brain [NA] & [5-HT] and functioning/ (-) results from CSF, plasma in depressed /individuals respond better to one AD than another
    – Most antidepressant drugs take several weeks for therapeutic effect but increase in amines acute (secondary adaptive changes more important)
    – Some antidepressants weak / no effect on amine uptake (e.g trazodone)/no increase in 5HT and NA but antidepressants!
    – Cocaine blocks amine uptake but has no antidepressant effect
    – Decrease in 5HT in dipolar linked to aggression rather than depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the neuroendocrine theory?

A

NAergic & 5-HT neurons input to
hypothalamus
*Hypothalamus releases corticotropin-
releasing hormone (CRH)
*CRH acts on pituitary – release of
adrenocorticotrophic hormone (ACTH)
*Cortisol release from adrenal cortex in
response to increase ACTH in blood - in time this may increase the basal levels of cortisol.

Neuroendocrine
– CRH – behavioural effects mimic some depression symptoms
– Evidence of hyperactivity of HPA in depressed patients
* increased [cortisol]plama in depressed patients
* increased [CRH] in the cerebrospinal fluid
– There is clear evidence that genes and environment can contribute to this hyperactivity and as such could offer an explanation for how genes x environment interaction can predispose people to mental health conditions (diathesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the underlying mechanism for children being predisposed to depression? How do genetics interact with the environment?

A

The HPA axis is regulated by the amygdala and the hippocampus.
Amygdala -> activates HPA = increase cortisol
Hippocampus -> suppress HPA = decreased cortisol

*Decreased’d hippocampal feedback in depression
*Decreased’d glucocorticoid receptors (cortisol receptors) in hippocampus
*Glucocorticoid receptor gene expression regulated by early experience
*Tactile stimulation just after
birth activates 5-HT pathways to
hippocampus
*5-HT triggers long-lasting increased in
expression of glucocorticoid
receptor gene
*increased in glucocorticoid receptors in hippocampus
*SSRIs increased glucocorticoid receptors in the hippocampus

In rats, pups neglected by mother, has lower levels of glucocorticoid receptors. This means HPA would not be able to activate hippocampus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the neuroplasticity and neurogenesis theory of depression?

A
  • Neuroplasticity & Neurogenesis
    – Evidence of neuronal loss and decreased neuronal activity in hippocampus and prefrontal cortex (decision making centres)

– Antidepressants and electroconvulsive therapy (ECT) promote neurogenesis in these regions

– 5-HT promotes neurogenesis during development (BDNF). (Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal survival and growth, serves as a neurotransmitter modulator, and participates in neuronal plasticity, which is essential for learning and memory.)

– Increase in Glutamate in Cx of depressed people (NMDA antagonists potential for depression treatment e.g. ketamine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the monoamine theory of depression?

A

Monoamine main theory of depression but needs to be extended
– Due to imbalances between NT (Monoamines, DA, Ach, CRF, CORT ect) producing long term alterations in gene expression, growth factors and NT (upregulation 5HT, NA receptors, HPA
hyperfunction and some neuronal loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is brain atrophy in depression?

A

In fMRIs, there seem to be a loss of neurones in the hippocampus associated in depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are possible treatments for depression?

A

Cognitive Behavioural Therapy
- Breaks the cycle of negative thoughts, behaviours and emotions. This is also psychosocial support.

Pharmacotherapy

17
Q

What are psychological treatments for depression?

A
  • Cognitive Behavioural Therapy: based on helping depressed individuals to recognise and change their negative cognitive processes and thus improve their mood and their counterproductive behaviours
  • Interpersonal Therapy: assumes that depression is multi-factorial but that interpersonal difficulties play a central role in maintaining depressive symptoms
18
Q

What are possible Pharmacological treatments for depression?

A
  • Tricyclic antidepressants
  • Monoamine oxidase inhibitors
  • Selective serotonin reuptake inhibitors
  • NICE recommends SSRIs for the pharmacological treatment
    of depression
  • Selectively inhibit the reuptake of serotonin in the synapse - less side effects.
  • Because they are more selective in the molecules to which
    they bind, they do not bind to receptors on other classes of
    neurons (fewer side effects)
19
Q

What are the long term neurochemical effects of AD?

A
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Tricyclic Antidepressant Drugs (TCAs)
  • Selective Serotonin Re-uptake Inhibitors (SSRIs)
  • Other mixed 5HT/NA reuptake inhibitors (SNRIs)
  • NA reuptake inhibitors
  • Monoamine receptor antagonists (a2, 5HT2c, 5HT3)
  • Downregulation a2, 5HT1A, b1, b2, 5HT2A, 5HT3
20
Q

What do MAOIs do?

A

*MAOI s increase [NA/5-HT]cytoplasm
*increase [NA/5-HT]cytoplasm increase leakage of amine
*increase [NA/5-HT] in synaptic cleft

The neurones contain serotonin, which is released, acts on receptors. The excess of Noradrenaline will go inside the neurones via the noradrenaline transporters. These are broken down via Monoamine oxidase enzyme. Action of NA is terminated.

Same thing with serotonin. Excess of serotonin outside will enters the neurone via 5-HT transporters, which will get broken down via MAO enzyme.

Depression caused by low levels of NA and 5-HT.
Antidepressants can fix this:

-Block Monoamines - without it, the NA and 5-HT will accumulate and release into the synaptic cleft.

21
Q

What are the effects of MAOIs?

A
  • Inhibition of MAO A correlates with AD activity
  • MAO-A 5-HT > NA
  • MAOIs rapidly increase [5-HT] > [NA] > [DA]
  • Increase NA=>Incr euphoria=>Incr motor activity
  • Early drugs e.g. phenelzine & isocarboxazid,
    irreversible and nonselective (Q. Why problem?)
  • Downregulation of post and presynaptic autoreceptors. a2, 5HT1A, b1, b2, 5HT2A, 5HT3
22
Q

How are MAO inhabitors a problem?

A

*Associated with food and drug interactions–

-Tyramine (in cheese and wine) acts as indirect sympathomimetic and increase NA release
– Excess NA destroyed by MAO – if blocked NA will accumulate
– NA accumulation (Increase headache, intracranial haemorrhage => elevation in BP => severe hypertension)
– MAOIs not specific – reduce metabolism of opioid analgesics and alcohol

23
Q

After the case with cheese and wine etc, how did they make MAO-I reversible?

A

Reversible MAOIs (RIMA) e.g. moclobemide
– Accumulation of NA displaces the RIMA allowing
degradation of excess NA
– RIMAs safer and selective RIMAs (e.g moclobemide) better tolerated (no major side effects)

24
Q

What is the Treatment: MAOIs Cheese Effect?

A

MAO in gut is inhibited
Dietary amines e.g. tyramine can get into the circulation
Foods include cheese, yoghurt, meat, wine, yeast products
All contain high concentrations of tyramine
Tyramine acts as an indirect sympathomimetic displacing - noradrenaline from vesicles

25
Q

What are some antidepressants?

A

Antidepressants (LOBs 3-5)

Monoamine oxidase inhibitors (part 2)
-Mechanism of action
-Side effects and underlining mechanism

Tricyclic antidepressants (part 2)
-Mechanism of action
-Side effects and underlining mechanism

Selective serotonin reuptake inhibitors (part 3)
-Mechanism of action
-Side effects and underlining mechanism

Future treatments

26
Q

What is Tricyclic antidepressant TCAs (second gen)?

A

Instead of blocking the MOI, they block the serotonin and Na transporters. The neurone can still release the chemicals, but they can’t get back inside again.

  • Main therapeutic effects:
    – NA reuptake inhibitor
    – 5-HT reuptake inhibitor
  • Initially increase[NA] & [5-HT] in synaptic cleft
  • Chronic treatment down regulation of
    – (β1) & 5-HT2
  • ⍺2, 5-HT1A/1D (autoR)
  • Also affect mACh, HR, 5HTR

Eg. Desipramine and Imipramine

27
Q

What is SSRIs (NICE recommendation-less
side effects)?

A

Just blosck the 5-HT transporters.

  • Main therapeutic effects:
    – 5-HT reuptake inhibitor
    – Chronic action:
    increase [5-HT] down regulation of 5-HT1A/1D
    autoreceptors, disinhibition of 5-HT
    neuron, increase 5-HT release
    – increase 5-HT release down regulates
    post synaptic 5-HT receptors ‘normalising’

5-HT 2A = Insomnia; sexual dysfunction; antidepressant; anti-OCD

5-HT3 =Nausea; GI distress; diarrhea; headache

28
Q

SSRIs safer & better tolerated (but long time to act!) - Why?

A

– Lack of anticholinergic effect and no cardiotoxicity – better compliance and recommended for long term use
– Broader therapeutic profile
* SSRIs generally not as effective as TCAs in severe depression (especially for suicide)
* Side effects:
– Insomnia & sexual dysfunction (5-HT2)
– Nausea; GI distress; headache (5-HT3)

29
Q

What are the side-effects of SSRI?

A
  • Shorter t½ risk of withdrawal effects
  • Increased risk of suicidal behaviour under 18
  • SSRIs may be associated with increased violence (5HT3)
  • Also used for anxiety, GAD and OCD
  • Not used in combination with TCA, MAO-I
    (inhibits TCA metabolism) - because it would also block the other components.
  • If you overdose on SSRI:
    (serotonin syndrome/tremor, seizures, hyperthermia, CV collapse)
30
Q

Why do antidepressants increase the surge in 5-HT and NA immediately, but doesn’t show any signs of improvement for 3-4 weeks?

A

Suggestions:
- When 5-HT releases from neurone, it binds both post-synaptically and pre-synaptically to serotonergic receptors. The pre-synaptic 5-HT autoreceptors are bound by serotonin, so when serotonin activates those receptors, there is an inhibition of the release of 5-HT

  • When somebody takes an SSRI, the serotonin transporters are blocked and there is a big release of serotonin in the synaptic cleft. Not initially big enough to induce anti-depressant. Will continually bind to pre and post synaptic receptors. Due to a composatory-homeostatic mechanism, which opposes this activation, the receptors will start down regulating. Decrease in numbers of both pre and post synaptic serotonergic autoreceptors. Consequently, after repeated use of SSRIs, there will be a disinhibition of 5-HT causing a big surge of 5-HT. Enough to be an antidepressant. Takes 2-3 weeks.
31
Q

What are the Future development of AD?

A
  • Drugs affecting monoamine transmission
    -b3 agonism, D2 agonism/antagonism, 5HT1A antagonism, 5HT2A antagonism with NA/5HT reuptake inhibition
  • Drugs affecting Ion channels
    • nACh agonist, antagonist, partial agonist
      -NMDA blockers (ketamine)
    • AMPA agonists
      -P2X, 5HT receptors, K+ channels
  • Cortisol receptor antagonist, M1/M2 agonist, NK1/NK2 antagonists
32
Q

What are the problems with AntiDepressants (AD)?

A
  • Side effects (especially insomnia=>relapse)
  • Toxic with overdose
  • Delayed effects
  • Non responsive in certain people (30-40% fail to
    improve with drug treatment)
  • Pharmacogenetics (P450, SERT polymorphisms
    associated with SSRI effectiveness)
  • More efficacious than placebo (BUT some
    people respond to one type of AD better than
    others)
33
Q

Are these any better than placebo?

A

Initial Severity and Antidepressant
Benefits: A Meta-Analysis of Data Submitted
to the Food and Drug Administration

Meta-analyses of antidepressant medications have reported only modest benefits over placebo treatment, and when unpublished trial data are included, the benefit falls below accepted criteria
for clinical significance. Yet, the efficacy of the antidepressants may also depend on the severity of initial depression scores. The purpose of this analysis is to establish the relation of baseline
severity and antidepressant efficacy using a relevant dataset of published and unpublished clinical trials.

34
Q

What are the Lithium treatments for Bipolar disorder treatment?

A
  • Lithium (Q. for what disorder?)
    – Mood stabilizer
    – Prophylactic use for depression, acute use mania
    – Li+ like Na+ gets into neurons but stays there=> depolarisation
    – Mode of action – inhibits enzymes involved in signal transduction (IP3, phosphorylation, GSK3, hormone induced cAMP inhibition)
    – Narrow therapeutic window
    – Takes 3-4 weeks to get benefit
    – Side effect: drowsiness, confusion, seizures, coma, weight gain, vomiting, renal effect (Na+ imbalance, retention due to increased aldosterone, polyurea), hypothyriodism (monitored)
35
Q

What are the other treatments for bipolar disorder? The mania part of it?

A
  • Ion channel blockers
    • Valproate, carbamazepine, topiramate?
      gabapentine, Pregabalin
  • Antipsychotics (mostly for mania)
    • D2 antagonist, 5HT2A antagonists, other
      receptors and transporters